A care team with the Sanger Heart & Vascular Institute has shared details about its recent successes in TMVR and TAVR. Cardiologist Michael Rinaldi, MD, highlighted the importance of having "a coordinated team of specialists with expertise in treating valve diseases."

The new analysis, based on data from more than 330,000 patients, is scheduled to be presented during ESC Congress 2022. 

The recall is related to short circuit protection (SCP) alerts that were causing the devices to send reduced-energy electric shocks. There have been 27 customer complaints about the issue so far.

A new scientific statement details the most common symptoms associated with heart attacks, heart failure and other cardiac conditions. Importantly, the authors wrote, clinicians must remember that symptoms can vary between men and women. 

Not all hospitals respect the written preferences of patients, possibly motivated by a desire to report better TAVR outcomes.

The new certification, based on recommendations published in Circulation, was developed to signal that a facility offers cardiac surgery and primary PCI at all times. 

Researchers tracked data from more than 12,000 moderate AS patients who originally participated in one of 25 different studies. While the findings seem to suggest earlier treatment could be beneficial for certain high-risk patients, additional research is still required.

While current guidelines endorse screening for people aged 65 and above, a massive simulation published in JAMA Health Forum suggests that cost-effectiveness may extend to even younger age groups.